Ultrasonic Nebulizers Market

Ultrasonic Nebulizers Market (Size: Small-volume Ultrasonic Nebulizer and Large-volume Ultrasonic Nebulizer; and Application: COPD, Asthma, Cystic Fibrosis, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Ultrasonic Nebulizers Market Outlook 2031

  • The global industry was valued at US$ 197.3 Mn in 2021
  • It is projected to grow at a CAGR of 5.4% from 2022 to 2031 and reach more than US$ 325.6 Mn by the end of 2031

Analysts’ Viewpoint

Rise in prevalence of respiratory diseases is expected to drive global ultrasonic nebulizers market size during the forecast period. Nebulizer is used to deliver medication directly to the lungs. Increase in consumer awareness about the benefits of home healthcare and availability of insurance coverage for respiratory conditions are anticipated to fuel market expansion. Growth in demand for portable nebulizers and technological advancements in ultrasonic nebulization technology are estimated to accelerate market development in the next few years.

Research and development of new technologies is likely to offer lucrative opportunities for vendors in the industry. Key players are launching advanced nebulizers in order to increase their ultrasonic nebulizers market share.

Ultrasonic Nebulizers Market

Ultrasonic Nebulizers Market Introduction

Ultrasonic nebulizer machines are devices that convert liquid medication into a fine mist, allowing it to be inhaled into the lungs. These devices are commonly used to treat respiratory conditions such as asthma and Chronic Obstructive Pulmonary Disease (COPD).

The mist created by the ultrasonic nebulizer is easily inhaled and deposited deep into the lungs, providing fast and effective relief from respiratory symptoms. Small-volume ultrasonic nebulizer and large-volume ultrasonic nebulizer are the two types of ultrasonic nebulizer.

Request a sample to get extensive insights into the Ultrasonic Nebulizers Market

Rise in Prevalence of Respiratory Disorders

The global ultrasonic nebulizer market is expected to be driven by the surge in prevalence of respiratory disorders such as asthma, COPD, and cystic fibrosis. Recent technological advancements have made nebulizers more portable and patient-friendly. Furthermore, various types of medications are widely available in nebulized formulations, enabling people with COPD, asthma, and other conditions to use nebulizers outside of acute care settings, such as clinics and hospitals.

According to the World Health Organization (WHO), around 235 million people had asthma across the globe, while an estimated 384 million people suffered from COPD, in 2021. The prevalence of cystic fibrosis is increasing, with around 70,000 cases reported globally in 2021.

Growth in Geriatric Population

Elderly people are more susceptible to respiratory disorders. Hence, demand for ultrasonic inhaler nebulizers is projected to increase among the geriatric population. According to the United Nations, the global population aged 60 years or above is likely to rise from 962 million in 2017 to 2.1 billion by 2050.

Prevalence of chronic respiratory diseases increases with age, and older adults are more likely to develop these conditions. Growth in demand for ultrasonic nebulizer among the elderly population is expected to fuel market progress.

Request a custom report on Ultrasonic Nebulizers Market

High Output of Medication in Short Time

In terms of size, the large-volume ultrasonic nebulizer segment held significant share of the global ultrasonic nebulizers market in 2021. Rise in prevalence of respiratory diseases such as COPD, asthma, and cystic fibrosis is anticipated to augment the segment in the next few years.

Large-volume ultrasonic nebulizers can produce high output of medication in a short period of time. These are typically used in hospitals and clinics for the treatment of respiratory disorders. The large-volume ultrasonic nebulizers segment is expected to witness robust growth during the forecast period due to the increase in demand in hospitals and clinics.

Increase in Incidence of Asthma

Based on application, the asthma segment is likely to account for major share of the global ultrasonic nebulizers market during the forecast period. Asthma is a chronic respiratory condition that affects millions of people across the world. Thus, increase in incidence of asthma is driving the demand for effective treatment options.

Ultrasonic nebulizers are commonly used to deliver medication to patients with asthma, as these devices can effectively break down medication into small particles that can be easily inhaled.

Regional Outlook of Global Ultrasonic Nebulizers Market

North America held the largest share of around 40.0% of the global ultrasonic nebulizers industry in 2021. The region is projected to be a highly lucrative market during the forecast period. North America's global dominance can be ascribed to the increase in incidence of respiratory disorders such as COPD, asthma, and others in the region.

The U.S. dominated the business in North America owing to factors such as presence of prominent players and increase in research & development activities.

Asia Pacific is projected to be the fastest growing ultrasonic nebulizers market during the forecast period. The market in the region is anticipated to expand at a high CAGR from 2022 to 2031 due to high incidence rate of respiratory disorders and increase in population.

Analysis of Key Players

The global ultrasonic nebulizers market is fragmented, with the presence of large number of players. Most of the companies are investing significantly in research & development activities, primarily to introduce innovative devices. Expansion of product portfolio and merger & acquisition are the key strategies adopted by companies in the global ultrasonic nebulizers market.

Koninklijke Philips N.V., OMRON Healthcare, Inc., Drive Medical, Invacare Corporation, Medline Industries, LP, Agilent Technologies, Inc., AireHealth, Inspired Medical, Mercury Medical, and Besmed are the prominent market players.

Key Developments in Global Ultrasonic Nebulizers Market

  • In December 2020, AireHealth announced that it had received FDA 510(k) clearance for VitalMed nebulizer. The portable device is intended to nebulize liquid medications for inhalation by patients in and out of the home.
  • In July 2020, OMRON Healthcare announced the addition of OMRON NE C106, a new compressor nebulizer, to its portfolio. The device offers ease of use, affordability, durability, and suitability for all members of a family. It also ensures quick and efficient drug delivery.

Each of these players has been profiled in the ultrasonic nebulizers market report based on parameters such as company overview, strategies, portfolio, segments, and recent developments.

Global Ultrasonic Nebulizers Market Snapshot

Attribute

Detail

Size in 2021

US$ 197.3 Mn

Forecast (Value) in 2031

More than US$ 325.6 Mn

Growth Rate (CAGR)

5.4%

Forecast Period

2022–2031

Historical Data Available for

2017–2020

Quantitative Units

US$ Mn for Value

Market Analysis

It includes segment analysis as well as regional level analysis. Furthermore, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis.

Competition Landscape

  • Market share analysis by company (2021)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials

Format

Electronic (PDF) + Excel

Market Segmentation

  • Size
    • Small-volume Ultrasonic Nebulizer
    • Large-volume Ultrasonic Nebulizer
  • Application
    • COPD
    • Asthma
    • Cystic Fibrosis
    • Others
  • End-user
    • Hospitals
    • Specialty Clinics
    • Others

Regions Covered

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Countries Covered

  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • China
  • India
  • Japan
  • Australia & New Zealand

Companies Profiled

  • Koninklijke Philips N.V
  • OMRON Healthcare, Inc.
  • Drive Medical
  • Invacare Corporation
  • Medline Industries
  • Agilent Technologies, Inc.
  • Inspired Medical
  • Mercury Medical
  • Besmed
  • AireHealth

Customization Scope

Available upon request

Pricing

Available upon request

Frequently Asked Questions

How big was the global ultrasonic nebulizers market in 2021?

The global industry was valued at US$ 197.3 Mn in 2021

How big will it be in 2031?

It is projected to reach more than US$ 325.6 Mn by 2031

What will be the CAGR during the forecast period?

The CAGR is anticipated to be 5.4% from 2022 to 2031

What are the prominent trends that affect growth?

Rise in prevalence of respiratory disorders and increase in geriatric population

Which region will account for major share during the forecast period?

North America is likely to account for significant share from 2022 to 2031

Who are the prominent players in the sector?

Koninklijke Philips N.V., AireHealth, OMRON Healthcare, Inc., Drive Medical, Invacare Corporation, Medline Industries, LP, Agilent Technologies, Inc., Inspired Medical, Mercury Medical, and Besmed

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global Ultrasonic Nebulizers Market

    4. Market Overview

        4.1. Introduction

            4.1.1. Definition

            4.1.2. Industry Evolution / Developments

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global Ultrasonic Nebulizers Market Analysis and Forecast, 2017–2031

    5. Key Insights

        5.1. Technological Advancements

        5.2. Disease Prevalence & Incidence Rate Globally With Key Countries

        5.3. Key Size/Brand Analysis

        5.4. COVID-19 Pandemic Impact on Industry (value chain and short/mid/long term impact)

    6. Global Ultrasonic Nebulizers Market Analysis and Forecast, by Size

        6.1. Introduction & Definition

        6.2. Key Findings/Developments

        6.3. Market Value Forecast, by Size, 2017–2031

            6.3.1. Small-volume Ultrasonic Nebulizer

            6.3.2. Large-volume Ultrasonic Nebulizer

        6.4. Market Attractiveness Analysis, by Size

    7. Global Ultrasonic Nebulizers Market Analysis and Forecast, by Application

        7.1. Introduction & Definition

        7.2. Key Findings/Developments

        7.3. Market Value Forecast, by Application, 2017–2031

            7.3.1. Chronic Obstructive Pulmonary Disease (COPD)

            7.3.2. Asthma

            7.3.3. Cystic Fibrosis

            7.3.4. Others

        7.4. Market Attractiveness Analysis, by Application

    8. Global Ultrasonic Nebulizers Market Analysis and Forecast, by End-user

        8.1. Introduction & Definition

        8.2. Key Findings/Developments

        8.3. Market Value Forecast, by End-user, 2017–2031

            8.3.1. Hospitals

            8.3.2. Specialty Clinics

            8.3.3. Others

        8.4. Market Attractiveness Analysis, by End-user

    9. Global Ultrasonic Nebulizers Market Analysis and Forecast, by Region

        9.1. Key Findings

        9.2. Market Value Forecast, by Region, 2017–2031

            9.2.1. North America

            9.2.2. Europe

            9.2.3. Asia Pacific

            9.2.4. Latin America

            9.2.5. Middle East & Africa

        9.3. Market Attractiveness Analysis, by Region

    10. North America Ultrasonic Nebulizers Market Analysis and Forecast

        10.1. Introduction

            10.1.1. Key Findings

        10.2. Market Value Forecast, by Size, 2017–2031

            10.2.1. Small-volume Ultrasonic Nebulizer

            10.2.2. Large-volume Ultrasonic Nebulizer

        10.3. Market Value Forecast, by Application, 2017–2031

            10.3.1. Chronic Obstructive Pulmonary Disease (COPD)

            10.3.2. Asthma

            10.3.3. Cystic Fibrosis

            10.3.4. Others

        10.4. Market Value Forecast, by End-user, 2017–2031

            10.4.1. Hospitals

            10.4.2. Specialty Clinics

            10.4.3. Others

        10.5. Market Value Forecast, by Country, 2017–2031

            10.5.1. U.S.

            10.5.2. Canada

        10.6. Market Attractiveness Analysis

            10.6.1. By Size

            10.6.2. By Application

            10.6.3. By End-user

            10.6.4. By Country

    11. Europe Ultrasonic Nebulizers Market Analysis and Forecast

        11.1. Introduction

            11.1.1. Key Findings

        11.2. Market Value Forecast, by Size, 2017–2031

            11.2.1. Small-volume Ultrasonic Nebulizer

            11.2.2. Large-volume Ultrasonic Nebulizer

        11.3. Market Value Forecast, by Application, 2017–2031

            11.3.1. Chronic Obstructive Pulmonary Disease (COPD)

            11.3.2. Asthma

            11.3.3. Cystic Fibrosis

            11.3.4. Others

        11.4. Market Value Forecast, by End-user, 2017–2031

            11.4.1. Hospitals

            11.4.2. Specialty Clinics

            11.4.3. Others

        11.5. Market Value Forecast, by Country/Sub-region, 2017–2031

            11.5.1. Germany

            11.5.2. U.K.

            11.5.3. France

            11.5.4. Italy

            11.5.5. Spain

            11.5.6. Rest of Europe

        11.6. Market Attractiveness Analysis

            11.6.1. By Size

            11.6.2. By Application

            11.6.3. By End-user

            11.6.4. By Country/Sub-region

    12. Asia Pacific Ultrasonic Nebulizers Market Analysis and Forecast

        12.1. Introduction

            12.1.1. Key Findings

        12.2. Market Value Forecast, by Size, 2017–2031

            12.2.1. Small-volume Ultrasonic Nebulizer

            12.2.2. Large-volume Ultrasonic Nebulizer

        12.3. Market Value Forecast, by Application, 2017–2031

            12.3.1. Chronic Obstructive Pulmonary Disease (COPD)

            12.3.2. Asthma

            12.3.3. Cystic Fibrosis

            12.3.4. Others

        12.4. Market Value Forecast, by End-user, 2017–2031

            12.4.1. Hospitals

            12.4.2. Specialty Clinics

            12.4.3. Others

        12.5. Market Value Forecast, by Country/Sub-region, 2017–2031

            12.5.1. China

            12.5.2. Japan

            12.5.3. India

            12.5.4. Australia & New Zealand

            12.5.5. Rest of Asia Pacific

        12.6. Market Attractiveness Analysis

            12.6.1. By Size

            12.6.2. By Application

            12.6.3. By End-user

            12.6.4. By Country/Sub-region

    13. Latin America Ultrasonic Nebulizers Market Analysis and Forecast

        13.1. Introduction

            13.1.1. Key Findings

        13.2. Market Value Forecast, by Size, 2017–2031

            13.2.1. Small-volume Ultrasonic Nebulizer

            13.2.2. Large-volume Ultrasonic Nebulizer

        13.3. Market Value Forecast, by Application, 2017–2031

            13.3.1. Chronic Obstructive Pulmonary Disease (COPD)

            13.3.2. Asthma

            13.3.3. Cystic Fibrosis

            13.3.4. Others

        13.4. Market Value Forecast, by End-user, 2017–2031

            13.4.1. Hospitals

            13.4.2. Specialty Clinics

            13.4.3. Others

        13.5. Market Value Forecast, by Country/Sub-region, 2017–2031

            13.5.1. Brazil

            13.5.2. Mexico

            13.5.3. Rest of Latin America

        13.6. Market Attractiveness Analysis

            13.6.1. By Size

            13.6.2. By Application

            13.6.3. By End-user

            13.6.4. By Country/Sub-region

    14. Middle East & Africa Ultrasonic Nebulizers Market Analysis and Forecast

        14.1. Introduction

            14.1.1. Key Findings

        14.2. Market Value Forecast, by Size, 2017–2031

            14.2.1. Small-volume Ultrasonic Nebulizer

            14.2.2. Large-volume Ultrasonic Nebulizer

        14.3. Market Value Forecast, by Application, 2017–2031

            14.3.1. Chronic Obstructive Pulmonary Disease (COPD)

            14.3.2. Asthma

            14.3.3. Cystic Fibrosis

            14.3.4. Others

        14.4. Market Value Forecast, by End-user, 2017–2031

            14.4.1. Hospitals

            14.4.2. Specialty Clinics

            14.4.3. Others

        14.5. Market Value Forecast, by Country/Sub-region, 2017–2031

            14.5.1. GCC Countries

            14.5.2. South Africa

            14.5.3. Rest of Middle East & Africa

        14.6. Market Attractiveness Analysis

            14.6.1. By Size

            14.6.2. By Application

            14.6.3. By End-user

            14.6.4. By Country/Sub-region

    15. Competition Landscape

        15.1. Market Player - Competition Matrix (by tier and size of companies)

        15.2. Market Share Analysis, by Company, 2021

        15.3. Company Profiles

            15.3.1. Koninklijke Philips N.V

                15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.1.2. Size Portfolio

                15.3.1.3. Financial Overview

                15.3.1.4. SWOT Analysis

                15.3.1.5. Strategic Overview

            15.3.2. OMRON Healthcare, Inc.

                15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.2.2. Size Portfolio

                15.3.2.3. Financial Overview

                15.3.2.4. SWOT Analysis

                15.3.2.5. Strategic Overview

            15.3.3. Drive Medical

                15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.3.2. Size Portfolio

                15.3.3.3. Financial Overview

                15.3.3.4. SWOT Analysis

                15.3.3.5. Strategic Overview

            15.3.4. Invacare Corporation

                15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.4.2. Size Portfolio

                15.3.4.3. Financial Overview

                15.3.4.4. SWOT Analysis

                15.3.4.5. Strategic Overview

            15.3.5. Medline Industries

                15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.5.2. Size Portfolio

                15.3.5.3. Financial Overview

                15.3.5.4. SWOT Analysis

            15.3.6. Agilent Technologies, Inc.

                15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.6.2. Size Portfolio

                15.3.6.3. Financial Overview

                15.3.6.4. SWOT Analysis

            15.3.7. Inspired Medical

                15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.7.2. Size Portfolio

                15.3.7.3. Financial Overview

                15.3.7.4. SWOT Analysis

            15.3.8. Mercury Medical

                15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.8.2. Size Portfolio

                15.3.8.3. Financial Overview

                15.3.8.4. SWOT Analysis

            15.3.9. Besmed

                15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.9.2. Size Portfolio

                15.3.9.3. Financial Overview

            15.3.10. AireHealth

                15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.10.2. Size Portfolio

                15.3.10.3. Financial Overview

                15.3.10.4. SWOT Analysis

    List of Tables

    Table 01: Global Ultrasonic Nebulizers Market Value (US$ Mn) Forecast, by Size, 2017–2031

    Table 02: Global Ultrasonic Nebulizers Market Value (US$ Mn) Forecast, by Application, 2017–2031

    Table 03: Global Ultrasonic Nebulizers Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 04: Global Ultrasonic Nebulizers Market Value (US$ Mn) Forecast, by Region, 2017–2031

    Table 05: North America Ultrasonic Nebulizers Market Value (US$ Mn) Forecast, by Country, 2017–2031

    Table 06: North America Ultrasonic Nebulizers Market Value (US$ Mn) Forecast, by Size, 2017–2031

    Table 07: North America Ultrasonic Nebulizers Market Value (US$ Mn) Forecast, by Application, 2017–2031

    Table 08: North America Ultrasonic Nebulizers Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 09: Europe Ultrasonic Nebulizers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 10: Europe Ultrasonic Nebulizers Market Value (US$ Mn) Forecast, by Size, 2017–2031

    Table 11: Europe Ultrasonic Nebulizers Market Value (US$ Mn) Forecast, by Application, 2017–2031

    Table 12: Europe Ultrasonic Nebulizers Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 13: Asia Pacific Ultrasonic Nebulizers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 14: Asia Pacific Ultrasonic Nebulizers Market Value (US$ Mn) Forecast, by Size, 2017–2031

    Table 15: Asia Pacific Ultrasonic Nebulizers Market Value (US$ Mn) Forecast, by Application, 2017–2031

    Table 16: Asia Pacific Ultrasonic Nebulizers Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 17: Latin America Ultrasonic Nebulizers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 18: Latin America Ultrasonic Nebulizers Market Value (US$ Mn) Forecast, by Size, 2017–2031

    Table 19: Latin America Ultrasonic Nebulizers Market Value (US$ Mn) Forecast, by Application, 2017–2031

    Table 20: Latin America Ultrasonic Nebulizers Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    Table 21: Middle East & Africa Ultrasonic Nebulizers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 22: Middle East & Africa Ultrasonic Nebulizers Market Value (US$ Mn) Forecast, by Size, 2017–2031

    Table 23: Middle East & Africa Ultrasonic Nebulizers Market Value (US$ Mn) Forecast, by Application, 2017–2031

    Table 24: Middle East & Africa Ultrasonic Nebulizers Market Value (US$ Mn) Forecast, by End-user, 2017–2031

    List of Figures

    Figure 01: Global Ultrasonic Nebulizers Market Value (US$ Mn) Forecast, 2017–2031

    Figure 02: Global Ultrasonic Nebulizers Market Value Share, by Size (2021)

    Figure 03: Global Ultrasonic Nebulizers Market Value Share, by End-user (2021)

    Figure 04: Global Ultrasonic Nebulizers Market Value Share, by Application (2021)

    Figure 05: Global Ultrasonic Nebulizers Market Value Share, by Region (2021)

    Figure 06: Global Ultrasonic Nebulizers Market Value Share Analysis, by Size, 2021 and 2031

    Figure 07: Global Ultrasonic Nebulizers Market Attractiveness Analysis, by Size, 2022–2031

    Figure 08: Global Ultrasonic Nebulizers Market Value Share Analysis, by Application, 2021 and 2031

    Figure 09: Global Ultrasonic Nebulizers Market Attractiveness Analysis, by Application, 2022–2031

    Figure 10: Global Ultrasonic Nebulizers Market Value Share Analysis, by End-user, 2021 and 2031

    Figure 11: Global Ultrasonic Nebulizers Market Revenue (US$ Mn), by Others, 2017–2031

    Figure 12: Global Ultrasonic Nebulizers Market Attractiveness Analysis, by End-user, 2022–2031

    Figure 13: Global Ultrasonic Nebulizers Market Value Share Analysis, by Region, 2021 and 2031

    Figure 14: Global Ultrasonic Nebulizers Market Attractiveness Analysis, by Region, 2022-2031

    Figure 15: North America Ultrasonic Nebulizers Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

    Figure 16: North America Ultrasonic Nebulizers Market Value Share (%), by Country, 2021 and 2031

    Figure 17: North America Ultrasonic Nebulizers Market Attractiveness Analysis, by Country, 2022–2031

    Figure 18: North America Ultrasonic Nebulizers Market Value Share Analysis, by Size, 2021 and 2031

    Figure 19: North America Ultrasonic Nebulizers Market Attractiveness Analysis, by Size, 2022–2031

    Figure 20: North America Ultrasonic Nebulizers Market Value Share Analysis, by Application, 2021 and 2031

    Figure 21: North America Ultrasonic Nebulizers Market Attractiveness Analysis, by Application, 2022–2031

    Figure 22: North America Ultrasonic Nebulizers Market Value Share Analysis, by End-user, 2021 and 2031

    Figure 23: North America Ultrasonic Nebulizers Market Attractiveness Analysis, by End-user, 2022–2031

    Figure 24: Europe Ultrasonic Nebulizers Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

    Figure 25: Europe Ultrasonic Nebulizers Market Value Share (%), by Country/Sub-region, 2021 and 2031

    Figure 26: Europe Ultrasonic Nebulizers Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

    Figure 27: Europe Ultrasonic Nebulizers Market Value Share Analysis, by Size, 2021 and 2031

    Figure 28: Europe Ultrasonic Nebulizers Market Attractiveness Analysis, by Size, 2022–2031

    Figure 29: Europe Ultrasonic Nebulizers Market Value Share Analysis, by Application, 2021 and 2031

    Figure 30: Europe Ultrasonic Nebulizers Market Attractiveness Analysis, by Application, 2022–2031

    Figure 31: Europe Ultrasonic Nebulizers Market Value Share Analysis, by End-user, 2021 and 2031

    Figure 32: Europe Ultrasonic Nebulizers Market Attractiveness Analysis, by End-user, 2022–2031

    Figure 33: Asia Pacific Ultrasonic Nebulizers Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

    Figure 34: Asia Pacific Ultrasonic Nebulizers Market Value Share (%), by Country/Sub-region, 2021 and 2031

    Figure 35: Asia Pacific Ultrasonic Nebulizers Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

    Figure 36: Asia Pacific Ultrasonic Nebulizers Market Value Share Analysis, by Size, 2021 and 2031

    Figure 37: Asia Pacific Ultrasonic Nebulizers Market Attractiveness Analysis, by Size, 2022–2031

    Figure 38: Asia Pacific Ultrasonic Nebulizers Market Value Share Analysis, by Application, 2021 and 2031

    Figure 39: Asia Pacific Ultrasonic Nebulizers Market Attractiveness Analysis, by Application, 2022–2031

    Figure 40: Asia Pacific Ultrasonic Nebulizers Market Value Share Analysis, by End-user, 2021 and 2031

    Figure 41: Asia Pacific Ultrasonic Nebulizers Market Attractiveness Analysis, by End-user, 2022–2031

    Figure 42: Latin America Ultrasonic Nebulizers Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

    Figure 43: Latin America Ultrasonic Nebulizers Market Value Share (%), by Country/Sub-region, 2021 and 2031 

    Figure 44: Latin America Ultrasonic Nebulizers Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

    Figure 45: Latin America Ultrasonic Nebulizers Market Value Share Analysis, by Size, 2021 and 2031 

    Figure 46: Latin America Ultrasonic Nebulizers Market Attractiveness Analysis, by Size, 2022–2031

    Figure 47: Latin America Ultrasonic Nebulizers Market Value Share Analysis, by Application, 2021 and 2031 

    Figure 48: Latin America Ultrasonic Nebulizers Market Attractiveness Analysis, by Application, 2022–2031

    Figure 49: Latin America Ultrasonic Nebulizers Market Value Share Analysis, by End-user, 2021 and 2031

    Figure 50: Latin America Ultrasonic Nebulizers Market Attractiveness Analysis, by End-user, 2022–2031

    Figure 51: Middle East & Africa Ultrasonic Nebulizers Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

    Figure 52: Middle East & Africa Ultrasonic Nebulizers Market Value Share (%), by Country/Sub-region, 2021 and 2031

    Figure 53: Middle East & Africa Ultrasonic Nebulizers Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

    Figure 54: Middle East & Africa Ultrasonic Nebulizers Market Value Share Analysis, by Size, 2021 and 2031

    Figure 55: Middle East & Africa Ultrasonic Nebulizers Market Attractiveness Analysis, by Size, 2022–2031

    Figure 56: Middle East & Africa Ultrasonic Nebulizers Market Value Share Analysis, by Application, 2021 and 2031

    Figure 57: Middle East & Africa Ultrasonic Nebulizers Market Attractiveness Analysis, by Application, 2022–2031

    Figure 58: Middle East & Africa Ultrasonic Nebulizers Market Value Share Analysis, by End-user, 2021 and 2031

    Figure 59: Middle East & Africa Ultrasonic Nebulizers Market Attractiveness Analysis, by End-user, 2022–2031

    Figure 60: Global Ultrasonic Nebulizers Market Share Analysis, by Company, 2021

Copyright © Transparency Market Research, Inc. All Rights reserved